
Fischer Medical Ventures appointed Mr. David Yeow, a seasoned engineer and medical device VC principal, as an Independent Director, enhancing board expertise. This led to Audit Committee reconstitution. The company also announced its 33rd Annual General Meeting.
Fischer Medical Ventures has fixed September 22, 2026, as the record date. Shareholders holding shares by this date will be eligible for dividends and can cast their e-votes at the Annual General Meeting (AGM) scheduled for September 29, 2026. The company's share transfer books will be closed from September 23...